Frontlight ResearchEarly access
Trial site
Norton Cancer Institute, Brownsboro Hospital Campus
- 7running trials
- 3closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Colorectal cancer4 trials
- Head and neck cancer3 trials
- Melanoma2 trials
- Metastatic breast cancer2 trials
- Pancreatic cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 35 trials
- Phase 24 trials
- Phase 1/21 trial
- Status
- Active, not recruiting5 trials
- Completed3 trials
- Not yet recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Seagen, a wholly owned subsidiary of Pfizer4 trials
- Pfizer3 trials
- BioAtla, Inc.2 trials
- CytoDyn, Inc.1 trial
Running trials
Recruiting
Recruiting
Active, not recruiting
CLOVER - CCR5-targeting Leronlimab With Oral Chemotherapy and VEGF-inhibitor Enriched Regimen
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer
Active, not recruiting
Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer1 recruiting
- Lung cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 19 Nov 2026